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Although attention has primarily been focused on theand Biochemistry
kinases involved in phosphorylation of IkBs, some NF-Howard Hughes Medical Institute
kB/Rel proteins, in particular p65, are also induciblyYale University School of Medicine
phosphorylated during the activation of NF-kB (Nau-New Haven, Connecticut 06520
mann and Scheidereit, 1994; Neumann et al., 1995).²Molecular Biology Program
However, the nature of this phosphorylation and its ef-Memorial Sloan-Kettering Cancer Center
fect on NF-kB activity are not yet understood.New York, New York 10021
Most Rel proteins have a consensus recognition site
(RRXS) for cyclic AMP±dependent protein kinase (PKA)
located approximately 25 amino acids N-terminal to theSummary
nuclear localizing signal (NLS) in the Rel homology do-
main (Mosialos and Gilmore, 1992). It has been sug-Stimulation of cells with inducers of NF-kB such as
gested that PKA-mediated phosphorylation of NF-kB isLPS and IL-1 leads to the degradation of IkB-a and
involved in the inducible and constitutive activation ofIkB-b proteins and translocation of NF-kB to the nu-
NF-kB (Blank et al., 1992; Verma et al., 1995). Naumanncleus. We now demonstrate that, besides the physical
and Scheidereit have demonstrated that, unlike p50 andpartitioning of inactive NF-kB to the cytosol, the tran-
c-Rel, p65 is constitutively phosphorylated in mature Bscriptionalactivity of NF-kBis regulated through phos-
cells and inducibly phosphorylated in Hela cells (Nau-phorylation of NF-kB p65 by protein kinase A (PKA).
mann and Scheidereit, 1994). Dephosphorylation ofThe catalytic subunit of PKA (PKAc) is maintained in
nuclear extracts from induced cells reduces the DNA-an inactive state through association with IkB-a or
binding activity of NF-kB in vitro. In addition, PKA canIkB-b in an NF-kB±IkB±PKAc complex. Signals that
phosphorylate the recombinant p65±p65 homodimercause the degradation of IkB result in activation of
and p65±p50 heterodimer, leading to an enhancementPKAc in a cAMP-independent manner and the subse-
of their DNA-binding activity. Further support for a rolequent phosphorylation of p65. Therefore, this pathway
of PKA in the activation of NF-kB comes from studiesrepresents a novel mechanism for the cAMP-indepen-
in Drosophila (Norris and Manley, 1992). In Drosophiladent activation of PKA and the regulation of NF-kB
Schneider cells, the nuclear translocation and transacti-activity.
vating ability of transfected Dorsal can be enhanced by
cotransfection of PKA, which phosphorylates Dorsal at
Introduction the PKA consensus site. It is also known that Dorsal
becomes phosphorylated concomitant with its transport
The transcription factor NF-kB consists of homodimers to the nucleus in the embryo (Whalen and Steward, 1993;
or heterodimers of proteins that belong to the Rel family Gillespie and Wasserman, 1994). Although transfection
(Verma et al., 1995; Baldwin, 1996). Members of this studies suggest that PKA increases the activity of NF-
family share a 300 aa (amino acid) region known as kB, some reports have indicated that elevation of cAMP
the Rel homology domain (Verma et al., 1995; Baldwin, reduces NF-kB activity, possibly by stabilizing IkB-a
1996). In mammalian cells, this family includes the onco- and impairing the nuclear transport of p65 (Chen and
gene v-rel, its cellular counterpart c-Rel, p105 (p50), Rothenberg, 1994; Neumann et al., 1995). However, the
p100 (p52), p65, and RelB. In Drosophila, two Rel pro- mechanism by which active PKA might stabilize IkB-a
teins have been described: Dorsal, a morphogen impor- has not yet been explained.
tant for dorso-ventral patterning; and Dif, an inducible Although these individual observations suggest that
transcription factor that is critical for immune responses PKA plays a role in regulating NF-kB activity, the mecha-
(Kopp and Ghosh, 1995; Baldwin, 1996). NF-kB/Rel tran- nism of PKA activation during induction of NF-kB re-
scription factors are present in most cell and tissue mains unknown. It is generally accepted that the only
types as inactive cytosolic proteins. The retention of NF- source of PKA is cytosolic, tetrameric complexes of the
kB in the cytosol is due to its interaction with inhibitory PKA regulatory and catalytic subunits (R2C2) (Taylor et
proteins called IkBs. NF-kB activity can be induced by al., 1990; Scott, 1991; Francis and Corbin, 1994; Walsh
a wide spectrum of signals, including mitogens, cyto- and Van Patten, 1994). Elevation of cAMP levels causes
kines, bacterial lipopolysaccharide, viruses, viral pro- binding of cAMP to the regulatory subunits, and the
teins, double-stranded RNA, and ultraviolet light (Kopp consequent allosteric change leads to release of the
and Ghosh, 1995). Despite the differences among these catalytic subunits. This active PKA affects both the regu-
signals, one of their common targets is the cytoplasmic lation of key metabolic enzymes and the expression of
numerous target genes. However, the inability of in-
ducers of NF-kB, such as LPS, IL-1, or PMA/PHA, to³Present address: Tularik Inc., 2 Corporate Drive, San Francisco,
California 04080. elevate cAMP levels has stymied efforts to formulate a
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mechanism that could explain how PKA might be acti- 1D). Immunoblot analysis of the same fractions with
vated in cells treated with these inducers. antibodies to PKAr and PKAc showed that while PKAr
We now demonstrate that the PKA catalytic subunit was present only in the fractions where PKA could be
(PKAc), but not the PKA regulatory subunit (PKAr), binds activated by cAMP (fractions 19±24), PKAc was present
IkB proteins and is associated with the NF-kB±IkB com- both in fractions containing PKAr (fractions 19±24) and
plex. PKAc interacts with IkB-a and IkB-b through se- with NF-kB±IkB complexes (fractions 13±18) (Figure 1D).
quences from the N terminus of the protein, and this As previously seen with PKAc that copurified with IkB-b
interaction inhibits the catalytic activity of PKAc. Stimu- (Figure 1B), the PKAc present in the NF-kB±IkB fractions
lation of cells with inducers of NF-kB activity, such as could not be activated by cAMP. To prove that the PKAc
LPS, that do not alter the levels of intracellular cAMP, detected in the NF-kB±IkB fractions was not intrinsically
leads to degradation of IkB proteins and the consequent defective, we carried out a denaturation-renaturation
activation of IkB-bound PKAc. Thus, this pathway repre- assay for PKA from a purified NF-kB±IkB±PKAc±con-
sents a novel mechanism by which a portion of PKA in taining fraction (fraction 16) that contained PKAc but
cells is regulated in a cAMP-independent manner. The did not exhibit PKA activity (Figures 1D and 1EI) (Hager
active PKAc then phosphorylates NF-kB p65 at the PKA and Burgess, 1980). Protein kinase activity was detected
consensus site in the Rel domain and leads to a dramatic from the slice corresponding to z42±45 kDa, which is
increase in the transcriptional activity of NF-kB. Specific around the expected molecular weight of PKAc (Figure
inhibition of PKA activity in cells stimulated with in- 1EII), demonstrating that association with NF-kB±IkB-
ducers of NF-kB potently inhibits transcriptional ac- a/b complexes inactives PKAc.
tivation by NF-kB, but not its nuclear translocation or
binding to DNA. Therefore, our studies reveal novel
mechanisms for regulating the transcriptional activity of PKAc Associates with IkB-a and IkB-b
NF-kB and the activity of a portion of PKA in a cAMP- in NF-kB±IkB Complexes
independent manner. To further examine the association of IkB proteins with
PKAc and PKAr, we generated constructs by fusing
IkB-a and IkB-b to glutathione S-transferase and ex-
Results pressed the recombinant fusion proteins inbacteria (Fig-
ure 2AI). We then mixed the purified GST±IkB proteins
The PKA Catalytic Subunit Copurifies with IkB-b with 35S-labeled PKAc, PKAr, and NF-kB p65, made by
During the purification of IkB-b protein from rabbit lung in vitro translation in rabbit reticulocyte lysates (Figure
cytosol (Figure 1A), we noticed a 42 kDa protein that 2AII). After a short incubation, the GST proteins were
copurified with IkB-b (Figure 1B) (Thompsonet al.,1995). precipitated by binding to glutathione±agarose beads
Sequencing of this 42 kDa polypeptide showed that it and were washed extensively, and the bound proteins
was the a isoform of the catalytic subunit of cyclic AMP-
were analyzed by SDS±PAGE, followed by fluorography
dependent protein kinase (PKAc a) (Figure 1C) (Scott,
(Figure 2AIII). As expected, only p65 and PKAc, but not
1991; Francis and Corbin, 1994). Because the pIs of
PKAr, were bound to the IkB proteins.
IkB-b and PKAc are markedly different (4.5 versus 8.6),
We then wanted to determine whether the interaction
the coelution of these proteins on ion exchange columns
between PKAc and IkB-a/IkB-b could be observed when
strongly suggested that they were associated with each
the various proteins were coexpressed in cells. We
other. However, to our surprise, we did not observe any
therefore cotransfected into COS-1 cells cDNAs encod-polypeptide between z52 and 55 kDa, corresponding
ing NF-kB p65 and IkB-a or IkB-b, along with a cDNAto the regulatory subunit of PKA (Figure 1B) (Scott, 1991;
encoding PKAc, tagged with an epitope from influenzaFrancis and Corbin, 1994). The absence of PKAr in these
virus. Following transfection, the cells were lysed andpreparations was also verified by immunoblotting (data
immunoprecipitations were performed with antibodiesnot shown). Since the activity of PKAc is normally inhib-
against IkB-a, IkB-b, and p65 (Figure 2B). The immuno-ited through its association with PKAr (Scott, 1991; Fran-
precipitates were fractionated by SDS±PAGE and immu-cis and Corbin, 1994), we wanted to determine if the
noblotted with an antibody against the flu epitope. InIkB-b-associated PKAc was catalytically active. We
all cases, the flu-tagged PKAc could be precipitated,therefore tested the purified IkB-b fractions containing
indicating that it was bound to both NF-kB±IkB-a andPKAc for kinase activity, using the phosphorylation of
NF-kB±IkB-b complexes (Figure 2B).a fluorescent kempeptide as an assay (see Experimental
The results presented above indicated that both inProcedures), but we could not detect any PKA activity
vitro and in transfected cells, PKAc could associate within these fractions, even in the presence of cAMP (data
IkB-a and IkB-b. To determine whether PKAc was anot shown). This suggested that association of PKAc
component of bothNF-kB±IkB-a and NF-kB±IkB-b com-with IkB-b caused inhibition of PKA catalytic activity.
plexes in vivo, we examined the composition of NF-To determine whether PKAc was also present in earlier
kB±IkB complexes in cells, using immunoprecipitationfractions from the purification of NF-kB±IkB, we chro-
and immunoblotting techniques. We began by immuno-matographed fractions from Sephacryl S-200 (step 4)
precipitating NF-kB±IkB complexes from 70Z/3 and Jur-(Figure 1A), that were enriched for NF-kB±IkB com-
kat cell extracts, using antibodies against NF-kB p65.plexes, on a Mono Q column. Assaying the fractions
The immunoprecipitates were fractionated by SDS±both for PKA activity in the presence of cAMP and for
PAGE and immunoblotted with an antibody directedNF-kB activity after deoxycholate (DOC) treatment indi-
against the catalytic subunit of PKA. PKAc was verycated that NF-kB±IkB complexes and the PKA holoen-
zyme (R2C2) could be separated from one another (Figure efficiently coimmunoprecipitated with p65, suggesting
PKA Regulates NF-kB Transcriptional Activity
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Figure 1. PKAc Copurifies with IkB-b from Rabbit Lung Cytosol
(A) The purification scheme used for purifying IkB-b from rabbit lung cytosol is shown (Thompson et al., 1995).
(B) A silver-stained gel of the peak fraction of purified IkB-b from the Superose 12 column (see Experimental Procedures).
(C) The protein sequence of the 42 kDa copurifying band reveals that it is the a isoform of the catalytic subunit of PKA. The three isoforms
of PKAc, although highly homologous, have some key differences (shown in bold) that allow them to be distinguished from one another. (X)
indicates amino acids that could not be unequivocally assigned by protein sequencing.
(D) The Sephacryl-S200 fraction (step 4 in Figure 1A) that contains partially purified NF-kB±IkB complex was chromatographed on a FPLC
MonoQ column, and the bound proteins were eluted with a gradient from 75 mM to 500 mM NaCl (the region of the gradient from 100 mM
to 400 mM NaCl is shown). The fractions containing protein (fractions 10±26) were assayed for NF-kB DNA-binding activity after DOC/NP-40
treatment, PKA activity with and without cAMP, and immunoblot analyses with antibodies to the catalytic subunit of PKA, the regulatory
subunit of PKA, IkB-a, and IkB-b. The cAMP-induced PKA activity was seen in fractions 19±24, fractions that also contained the PKAc and
PKAr subunits. The NF-kB±IkB complex containing fractions 12±18 does not contain PKAr but does have PKAc.
(E) (I): Fraction 16 contains DOC-induced NF-kB activity but no cAMP-induced PKA activity, in contrast to fraction 22, which does not contain
NF-kB activity but has cAMP-induced PKA activity. (II): To determine whether the PKAc protein seen on immunoblots of fraction 16 was
active, a denaturation-renaturation assay for PKA activity was performed on 300 ml of this fraction (Hager and Burgess, 1980). PKA activity
was only detected from the slice around 42±45 kDa (slice 5). The photograph of the agarose gel used for the fluorescent kempeptide assay
is on the left, while the quantitation of the assay is on the right.
that it was associated with NF-kB±IkB complexes (Fig- with antibodies against IkB-a or IkB-b and used immu-
ure 2C, lanes 1 and 3). Boiling the extracts before immu- noblotting to examine whether PKAc was present in
noprecipitation resulted in the loss of coimmunoprecipi- both immunoprecipitates (Figure 2E). Again, the results
tating PKAc, suggesting that it was bound to NF-kB±IkB indicated that PKAc could be immunoprecipitated with
complexes by noncovalent interactions (Figure 2C, both NF-kB±IkB-a and NF-kB±IkB-b complexes (Figure
lanes 2 and 4). We then wanted to determine whether 2E, upper panel, lanes 3 and 4). If a parallel blot was
IkB-a, IkB-b, or both IkBs could be coprecipitated with probed with the PKAr antibody, the results indicated
PKAc. Therefore, we carried out immunoprecipitations that PKAr was only coprecipitated with PKAc (Figure
with antibodies against PKAc and PKAr and analyzed 2E, lower panel, lane 5). Hence, these results clearly
the precipitated proteins by immunoblotting with anti- establish the presence of two pools of PKAc in cells,
bodies against IkB-a and IkB-b (Figure 2D). The PKAc one bound to PKAr and another bound to NF-kB±IkB
immunoprecipitates contained both IkB-a (Figure 2D, complexes.
lane 1) and IkB-b (Figure 2D, lane 4), while the PKAr
immunoprecipitates contained neither of the two IkB
The ATP-Binding Domain of the PKAisoforms (Figure 2D, lanes 2 and 5). Incubating parallel
Catalytic Subunit Interacts with IkBblots with antibodies to PKAc indicated the presence
The lack of PKA activity in the purified IkB/PKAc frac-of PKAc in both immunoprecipitates (Figure 2D, lanes
tions (Figure 1A and data not shown) and in purified NF-7 and 8). Therefore, this result demonstrated that PKAc
kB±IkB±PKAc complexes (Figure 1D) suggested that theis present in both NF-kB±IkB-a and NF-kB±IkB-b com-
plexes. Finally, we carried out immunoprecipitations binding of IkB to PKAc inhibits the enzymatic activity
Cell
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Figure 2. PKAc, but Not PKAr, Directly Asso-
ciates with IkB-a and IkB-b
(A) The PKAc, PKAr, and NF-kB p65-encod-
ing cDNAs were translated in vitro using the
TNT system from Promega. The purified GST
proteins (Thompson et al., 1995) (z0.5 mg)
were mixed with 1 ml of the in vitro translated
proteins and incubated on ice for 10 min, and
then glutathione±agarose beads were used
to pull down proteins associated with the GST
proteins. The beads were washed, and the
precipitated proteins were fractionated on
SDS±PAGE and analyzed by fluorography.
(B) Expression vectors (pCDNA3) containing
cDNAs for NF-kB p65 (lanes 1±4) and HA (flu)-
tagged PKAc (lanes 1 and 2) with either
IkB-b (lanes 1 and 3) or IkB-a (lanes 2 and 4)
were used for transfection into COS-1 cells.
(I): Twenty-four hours after transfection, ex-
tracts were prepared and immunoblots were
carried out with anti-IkB-b (upper panel, lanes
1 and 3), anti-IkB-a (upper panel, lanes 2 and
4), and anti-flu antibody (lower panel) to de-
termine the expression of the transfected
constructs. (II): Immunoprecipitations were
then carried out on the extracts using the
indicated antibodies. After extensive washing
of the PAS immunoprecipitates, the bound
proteins were eluted by boiling in SDS sample
buffer and fractionated on SDS±PAGE, fol-
lowed by immunoblotting with anti-HA anti-
bodies.
(C) Immunoprecipitations were carried out
using antibodies against NF-kB p65, from cy-
tosolic extracts of 70Z/3 and Jurkat cells
(lanes 1 and 3). Identical immunoprecipita-
tions were carried out on samples that had
been boiled with SDS and neutralized with
Triton X-100 before adding the immunopre-
cipitating antibody (lanes 2 and 4). The immu-
noprecipitates were fractionated on SDS±
PAGE and then immunoblotted with an antibody against PKAc. The absence of PKAc in the boiled samples (lanes 2 and 4) indicated that
PKAc was associated with NF-kB±IkB complexes by noncovalent interactions.
(D) Extracts from 70Z/3 cells were immunoprecipitated with antibodies against PKAc and PKAr. The immunoprecipitates were fractionated
on 10% SDS±PAGE and analyzed by immunoblotting with antibodies against IkB-a (lanes 1±3), IkB-b (lanes 4±6), and PKAc (lanes 7±9). The
boiled controls were precipitated with the PKAc antibody.
(E) Immunoprecipitations on 70Z/3 cells were carried out as in Figure 2D, with antibodies against p65, IkB-a, IkB-b, and PKAc. The immunopre-
cipitates were analyzed by immunoblotting after SDS±PAGE, using antibodies against PKAc (upper panel) or PKAr (lower panel). The boiled
control was precipitated with IkB-b antibody.
of PKA. To demonstrate that IkB proteins can directly interaction with IkBs (Figure 3BIII). The three-dimen-
sional structure of PKAc has revealed that the proteininhibit PKA activity, we performed an assay in which
increasing amounts of GST±IkB-a, GST±IkB-b, GST, and has a bilobate structure, a smaller lobe made up primar-
ily of sequences from the N terminus (amino acids 40±PKAr were added to a fixed amount of purified PKAc
(Figure 3A). The results showed that both IkB-a and 125) and a larger lobe consisting primarily of sequences
from the C terminus (amino acids 140±280) (Knighton etIkB-b were able to inhibit the catalytic activity of the
purified PKAc preparation (Figure 3A). al., 1991a, 1991b). The catalytic site of the kinase is
localized in a deep cleft between the two lobes. TheThe catalytic activity of PKAc is inhibited by its regula-
tory subunit PKAr through a direct masking of the sub- smaller N-terminal lobe is primarily used for binding to
ATP, while substrate binding is carried out with se-strate binding domain (Francis and Corbin, 1994; Walsh
and Van Patten, 1994). To determine whether IkBs were quences from the larger, C-terminal lobe. Therefore, the
region of PKAc that appears to be critical for interactionalso inhibiting the catalytic activity of PKAc through a
similar mechanism, we set up an experiment to map the with IkBs is different from the substrate binding region
of PKAc that is masked by the regulatory subunit (Fran-region in PKAc used for interaction with IkB. We tested
the ability of GST±IkB-a and GST±IkB-b proteins to inter- cis and Corbin, 1994). Hence, the lack of PKA activity
in IkB-PKAc complexes (Figure 1A) is possibly due toact with different 35S-labeled deletions of PKAc (Figures
3BI and 3BII). The results of the pull-down experiment the masking of the ATP-binding domain of PKAc.
If the interaction of IkB with PKAc is confined to theindicated that sequences toward the N terminus of PKAc
(minimally, from amino acids 46±76) were critical for N-terminal ATP-binding domain, it might leave the C-ter-
PKA Regulates NF-kB Transcriptional Activity
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Figure 3. Inhibition of PKA Activity by IkB Is
Due to Masking of the Catalytic Domain
(A) Activity of PKA was measured by using
the fluorescent kempeptide assay system
(see Experimental Procedures). PKA activity
was determined from the ratio of phosphory-
lated peptide to total peptide, by quantitating
the amount of each peptide after scanning
photographs of the agarose gels. The PKAc
and the PKAr used were purified proteins
from bovine brain. The purified GST±IkB pro-
teins were the same as described earlier (Fig-
ure 2A). In each case, 10 ng of PKAc was
used, while the amount of GST±IkB-a, GST±
IkB-b, GST, and PKAr varied from 20 ng to
80 ng.
(B) (I): Deletions from the C terminus of PKAc
were made by truncating the plasmid con-
taining the cDNA at various sites and in vitro
translating these templates. (II): The proteins
truncated from the N terminus of PKAc were
generated by subcloning these smaller pro-
teins into pCDNA3, followed by their expres-
sion in vitro in reticulocyte lysates. The
amount of lysates added to each assay con-
tained approximately equal amounts of the
truncated PKAc proteins, as determined by
analyzing the proteins on a 17.5% SDS±
PAGE. (III): The proteins associating with the
GST±IkB proteins were precipitated by using
glutathione±agarose and analyzed by SDS±
PAGE and fluorography.
(C) The 35S-labeled Rel proteins translated in
vitro, mixedwith GST-PKAc, and precipitated
by binding to glutathione±agarose beads.
The precipitated proteins were analyzed by
SDS±PAGE and fluorography. (I): Each in vitro
translated protein (4 ml) was analyzed by
SDS±PAGE and fluorography. (II): To com-
pensate for the more efficient translation of
p65 and PKAr, 0.5 ml of p65, 1 ml of PKAr,
and 5 ml of the other proteins (p50, IkB-a, and
IkB-b) were used for the pull-down exper-
iment.
minal substrate binding domain of PKAc partially un- Stimulation with NF-kB Inducers Activates
PKA without Altering cAMP Levelsmasked. Since we knew that PKAr is not a component
of the NF-kB±IkB complexes, it appeared likely that this Because binding of PKA to IkB inhibits kinase activity,
we assumed that the removal of IkB should activate theregion of PKAc interacts with either p50 or p65, since
they both contain consensus PKA phosphorylation sites bound PKA. Stimulation of cells with inducers of NF-kB
activity, such as LPS, results in the phosphorylation andand therefore can act as substrates (Mosialos and Gil-
more, 1992). To test whether PKAc displays any prefer- degradation of IkB-a and IkB-b proteins (Thompson et
al., 1995; Baldwin, 1996). Therefore, we wanted to testence between p50 and p65, we produced a GST±PKAc
protein and mixed it with 35S-labeled, in vitro translated whether the degradation of IkBs correlates with the acti-
vation of PKA in LPS-stimulated cells. We stimulatedp50, p65, and PKAr proteins (Figure 3C). Surprisingly,
precipitation of complexed proteins with glutathione± 70Z/3 pre-B cells with LPS for up to 2 hr, a period in
which the majority of IkB-a and IkB-b is degraded (Fig-agarose indicated that GST±PKAc forms a stable com-
plex with only p65, and not p50. To further localize the ure 4A) (Thompson et al., 1995; SuYang et al., 1996).
Assaying the extracts for PKA activity revealed that PKAsequences on PKAc that interact with p65, we used a
truncated PKAc that contained sequences from the C is activated in these cells in a manner that correlates
with the degradation of IkBs (Figure 4B). As a control,terminus of the protein (amino acids 159±350) for the
pull-down experiment and confirmed that the C-terminal we used forskolin, which does not affect IkB (Figure
4A) but activates PKA by dissociating the PKA R2C2substrate binding domain of PKAc binds to p65 (data
not shown). These interaction experiments therefore complexes through elevation of cAMP levels (Figure 4B)
(Francis and Corbin, 1994; Walsh and Van Patten, 1994).suggest a model in which the N-terminal ATP-binding
domain of PKAc binds to IkB, while the C-terminal region To rule out the possibility that activation of PKA in LPS-
treated cells is due to an increase in cellular levels ofestablishes interactions with the substrate p65 protein.
Dual sites of interaction might thus allow PKAc to bind cAMP, we measured the level of cAMP in cell extracts
using a Biotrak enzyme immunoassay kit (Amersham)stably and avidly to the NF-kB±IkB complex.
Cell
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Figure 5. Proteasome Inhibitors Affect LPS-Dependent, but Not
cAMP-Dependent, Activation of PKA
(A) 70Z/3 cells were treated with 10 mM, 25 mM, or no calapain
inhibitor I, before stimulating with 10 mg/ml LPS for 60 min. A parallel
experiment was performed in which 70Z/3 cells were stimulated
with 50 mM dibutyryl cAMP with or without pretreatment with calpain
inhibitor I. Extracts were made from the cells and used for immu-Figure 4. Stimulation with LPS Activates PKA but DoesNot Increase
noblot analysis.cAMP Levels
(B) PKA activity was measured from the same samples as (A), using(A) 70Z/3 pre-B cells were treated with 10 mg/ml LPS or 20 mM
the fluorescent kempeptide assay.forskolin for the indicated periods. Cytosolic and nuclear extracts
(C) Immunoprecipitations were carried out with antibodies againstwere prepared, and the nuclear extracts were used to examine NF-
NF-kB p65, from extracts of cells treated with LPS or dibutyrylkB DNA binding in EMSA, whereas the cytosolic extract was used
cAMP, with or without calapain inhibitor I, as shown in (A). Theto perform immunoblots with antibodies to IkB-a and IkB-b.
immunoprecipitates were analyzed on SDS±PAGE and immunoblot-(B) Total cell extracts from 70Z/3 cells, stimulated as in (A) and made
ted with an antibody against PKAc.in parallel, were used to determine the activity of PKA using the
fluorescent kempeptide assay. The mean values and standard devi-
ations are shown; at least three independent experiments were done
IkB-b (Verma et al., 1995; Baldwin, 1996). Pretreatmentfor each condition. The activity of PKA is presented as fold activity
compared to uninduced cells. of cells with peptide aldehyde inhibitors such as calpain
(C) The same samples as in (B) were used to determine the amount inhibitor I, MG132, or PSI efficiently blocks the degrada-
of cAMP, using a Biotrak EIA assay kit (Amersham). tion of phosphorylated IkBs in stimulated cells (Verma
et al., 1995; Baldwin, 1996). We treated 70Z/3 cells with
LPS or dibutyryl cAMP, with or without pretreatment
with calpain inhibitor I. The cellular extracts were then(Figure 4C). As expected, cells stimulated with forskolin
showed an z30-fold increase in cellular cAMP levels. immunoblotted to determine the levels of IkB-a and
IkB-b proteins (Figure 5A) and assayed for PKA activityIn contrast, cells stimulated with LPS demonstrated no
significant change in cAMP levels. Therefore, the in- (Figure 5B). We also carried out immunoprecipitations
with the p65 antibody, followed by immunoblotting withcrease in PKA activity in LPS-treated cells was not de-
pendent on changes in cAMP levels. the PKAc antibody to determine the amount of PKA
that remained associated with NF-kB±IkB complexes in
these stimulated cells (Figure 5C). The results showedProteasome Inhibitors Block LPS-Dependent,
but Not cAMP-Dependent, Activation of PKA that treatment of cells with both LPS and dibutyryl
cAMP, an analog of cAMP, activated PKA (Figure 5B);To prove that activation of PKA in LPS-treated cells is
the result of degradation of IkB-a and IkB-b, we used however, only LPS treatment caused the degradation
of IkB-a and IkB-b (Figure 5A). Pretreatment of cellscalpain inhibitor I to block signal-induced IkB degrada-
tion. It has been demonstrated previously that treatment with calpain inhibitor I blocked both IkB degradation
(Figure 5A, lane 3) and PKA activation (Figure 5B) inof cells with inducers of NF-kB activity (e.g., LPS) leads
to the phosphorylation and degradation of IkB-a and LPS-stimulated cells, but did not affect activation of
PKA Regulates NF-kB Transcriptional Activity
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Figure 6. Inhibition of NF-kB Activation by In-
terfering with PKA
(A) Jurkat cells were transfected with the
pBIIx luc, an NF-kB-dependent reporter con-
struct, using lipofectamine reagent (GIBCO-
BRL). Twenty-four hours after transfection
the cells were treated with PMA/PHA, with or
without H-89 or ML-7, at the indicated con-
centrations. The cells were then lysed, and
the total cell extracts wereused both to assay
for kB-specific DNA binding and for luciferase
activity.
(B) Hela cells transfected with pBIIx luc, were
used for permeabilization. Following permea-
bilization with the TransPort reagent (GIBCO-
BRL), the inhibitory PKI peptide and the con-
trol peptide (which inhibits casein kinase II
autophosphorylation) were added to the
cells. After allowing the peptides to enter,
cells were treated with PMA/PHA for 4 hr,
after which they were harvested and lysed
and the activity of luciferase was determined.
(C) A schematic diagram of the PKAc protein
with the mutation at lysine 73 into methionine
is shown.
(D) Jurkat cells were transfected with pBIIx
luc, alone or with PKAc, wild-type or the mu-
tant. Twenty-four hours after transfection, the
cells were stimulated with PMA/PHA, and the
expression of the luciferase reporter was
quantitated.
PKA in cells treated with dibutyryl cAMP (Figures 5A construct, pBIIx luc, as an assay. We observed dramatic
inhibition of PMA/PHA-induced, NF-kB-dependent tran-and 5B). In all cases, the activation of PKA by LPS corre-
lated with the loss of PKAc in p65 immunoprecipitates scription in the presence of 10 mM H-89 (Figure 6AII), a
concentration that does not affect DNA binding by NF-(Figure 5C, lane 3). However, in LPS-stimulated cells
pretreated with calpain inhibitor I, PKAc could still be kB (Figure 6AI, lane 4). In contrast, ML-7, when used
coimmunoprecipitated with p65 (Figure 5C, lanes 4 and at up to 40 mM, had little effect on NF-kB-dependent
5). Therefore, the degradation of IkB proteins in LPS- transcription (Figure 6AII). This experiment provides
stimulated cells leads to the release and activation of strong evidence for the involvement of PKA in modulat-
the associated PKAc. ing transcriptional activation by NF-kB without affecting
DNA binding by NF-kB.
We next used the specific PKA inhibitory peptide, PKIInhibition of NF-kB Activation
(amino acids 6±22) amide, to examine the role of PKAupon Interfering with PKA
in NF-kB-dependent transcription (Figure 6B). PKI is aTo elucidate the possible role of PKA-mediated phos-
16 aa peptide that contains a PKA pseudosubstratephorylation on NF-kB function, we used three different
sequence and specifically inhibits PKAc by binding toapproaches to specifically inhibit PKA activity in cells.
the substrate binding site (Ki of z1.7 nM). To allow theWe first used the isoquinoline-sulfonamide derivative,
peptide to enter the cell, we permeabilized the cells withH-89, which is one of the most potent inhibitors of PKA
the TransPort cell permeabilization kit (GIBCO-BRL),(Ki [inhibition constant] of z0.048 mM). As a control, we
which does not lead to a significant loss of cytosolicused ML-7, another inhibitor that is specific for myosin
components. Hela cells transfected with the NF-kB-light chain kinase. We tested the effect of the two inhibi-
dependent luciferase reporter construct were perme-tors on LPS-induced activation of NF-kB and found that
abilized 24 hr after transfection and were treated withboth inhibitors had little effect on the NF-kB DNA-bind-
either the PKI inhibitory peptide or a control peptide,ing complex (Figure 6AI, lanes 3±5). We then tested the
which competitively inhibits casein kinase II autophos-effect of these inhibitors on NF-kB-dependent transcrip-
tion, using the expression of luciferase from a reporter phorylation. After allowing the peptides to enter, the
Cell
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cells were stimulated with PMA/PHA for 4 hr and lucifer- were stimulated with LPS. We therefore metabolically
labeled unstimulated and LPS-stimulated 70Z/3 cellsase activity was assessed. Although permeabilization
with 32Pi and immunoprecipitated labeled proteins usingitself caused a slight decrease in the level of reporter
the p65 antibody. A number of 32P-labeled proteins weregene expression, the inclusion of the PKI peptide, but
seen, including a protein around 65 kDa (Figure 7B, lanenot the control peptide, caused nearly complete inhibi-
2), and we confirmed that this 65 kDa protein was p65tion (.90%) of reporter gene expression (Figure 6B).
by reimmunoprecipitating with the p65 antibody (FigureFinally, we generated a mutant, catalytically inactive
7B, lane 4). We then used the dual immunoprecipitationform of PKAc by altering lysine 73 in PKAc to a methio-
technique to examine the effect of inhibiting IkB degra-nine (K73M) (Figure 6C). A similar change to a conserved
dation on the inducible phosphorylation of p65. Welysine has been demonstrated to inactivate other ki-
treated 32P-labeledcells with either PDTC (anantioxidantnases (Taylor et al., 1990; Scott, 1991). We verified that
that prevents signal-induced phosphorylation of IkB),this mutation results in a catalytically inactive form of
calpain inhibitor I (which blocks the degradation of in-PKA by expressing it in COS cells and assaying PKA
ducibly phosphorylated IkB), or H-89 (which inhibitsactivity (data not shown). We then tested the ability of
PKA). The results of the labeling experiments indicatethis mutated kinase to interfere with NF-kB function
that both PDTC and calpain inhibitor I completely blockby cotransfecting it with the kB-dependent luciferase
the inducible phosphorylation of p65 (Figure 7B, lanesreporter construct. We expected the transfected mutant
5 and 6), whereas H-89 inhibits such phosphorylationPKAc to interfere with PKAc-dependent activation of
(Figure 7B, lane 7). Therefore, the inducible phosphory-NF-kB, and, as shown in Figure 6D, introduction of this
lation of p65 upon LPS treatment appears to be depen-mutant form into cells caused a dramatic decrease in
dent on the degradation of IkB and the activity of PKA.the amount of transcription from the reporter construct
To further localize the site of phosphorylation on p65 inwhen cells were stimulated with PMA/PHA. In contrast,
LPS-stimulated cells, we isolated the inducibly phos-transfection of wild-type PKAc along with the reporter
phorylated p65 protein and digested it with either tryp-construct exhibited marginal effects on PMA/PHA-
sin, chymotrypsin, LysC, or CNBr (Figure 7C). The phos-induced transcription (Figure 6C). This result further
phopeptides were then separated on a high-resolutionstrengthens thehypothesis that phosphorylation by PKA
Tris-tricine gel system (Schagger and von Jagow, 1987).enhances transcriptional activation mediated by NF-kB.
The sizes of the phosphopeptides obtained (z9 kDa for
Since neither activation of PKA alone (Figure 4A) nor
LysC, z3.4 kDa for chymotrypsin, z1.5 kDa for CNBr,
inhibition of PKA by H-89 (Figure 6A) affects the nuclear
and z0.5 kDa for trypsin), when compared to predicted
translocation and DNA binding by NF-kB, the role of
peptides based on the sequence, indicated that they
PKA appears to bea modulator of transcriptional activity
most likely include Ser 276 of the p65 protein (Figure
of NF-kB entering the nucleus.
7C). These results therefore suggest that the inducible
phosphorylation of p65 in LPS-stimulated cells occurs
on Ser 276 in the consensus PKA phosphorylation site.Transcriptional Activity of NF-kB Is Stimulated
We then generated a site-directed mutant of p65 inby Phosphorylation of p65 by PKA
which the serine 276 was altered to a nonphosphorylat-
A possible mechanism to explain the effect of PKA on
able alanine residue (S276A) (Figure 7D). We tested the
transcription by NF-kB might be the direct phosphoryla-
ability of this protein to transactivate the kB-dependent
tion of NF-kB subunits by PKAc at the consensus site for reporter construct upon transfection into COS cells. Im-
PKA phosphorylation. Although almost all Rel proteins munoblots of the transfected cells indicated that both
have a conserved PKA phosphorylation site (Mosialos the wild-type and mutant p65 proteins were expressed
and Gilmore, 1992), previous studies have shown that in equivalent amounts (data not shown). However, there
only inducibly phosphorylated p65 and p105 can be was a marked difference in the ability of the two p65
detected in stimulated Hela and Jurkat cells (Naumann forms to transactivate, as measured by the expression
and Scheidereit, 1994; Neumann et al., 1995). Since of luciferase from a reporter construct (Figure 7D). To
PKAc is directly associated with IkB-a and IkB-b, which examine the effect of PKA on transactivation by NF-kB,
in turn interactsonly with p65, it is possible that degrada- we cotransfected Jurkat cells with wild-type or K73H
tion of IkB proteins allows PKA to specifically phosphor- mutant PKAc and wild-type or S276A mutant p65, and
ylate p65. We have also found that PKAc interacts with measured kB-dependent luciferase activity (Figure 7E).
only p65, and not p50, through its substrate binding Transfection of wild-type or mutant PKAc alone had no
region (Figure 3C and our unpublished data), and there- effect on NF-kB. Transfection of wild-type and mutant
fore, degradation of IkBs should lead to a preferential p65 alone resulted in low levels of expression of lucifer-
phosphorylation of the bound p65 protein. ase, as seen earlier (Figure 7D). Cotransfection of PKAc
To directly demonstrate that PKAc can phosphorylate with p65 led to a dramatic increase in the expression
p65, we used a truncated form of p65 (amino acids of the reporter gene, and this increase was not seen if
1±313), which retains the Rel homology domain and the the K73M mutant of PKAc was used (Figure 7E). The
PKA phosphorylation site, as a substrate for PKA phos- reciprocal experiment, in which wild-type PKAc was
phorylation. This purified, bacterially expressed p65 pro- transfected with wild-type and S276A mutant p65, re-
tein was efficiently phosphorylated by purified PKAc vealed the same effect on NF-kB-dependent transcrip-
(Figure 7A, lane 1), and thephosphorylation was blocked tion (Figure 7E). These results provide compelling evi-
by the inclusion of the PKA inhibitory peptide, PKI (Fig- dence that phosphorylation of p65 by PKA at serine
ure 7A, lane 2). We then wanted to determine whether 276 causes a significant stimulation of transcriptional
activity of NF-kB.p65 was inducibly phosphorylated by PKA when cells
PKA Regulates NF-kB Transcriptional Activity
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Figure 7. Transcriptional Activity of NF-kB Is
Affected by Phosphorylation of p65 by PKA
(A) A truncated version of p65 from residues
1±313 was expressed in bacteria and purified
to near homogeneity. The purified protein (30
ng) was used as a substrate for phosphoryla-
tion by 20 U of purified PKAc. Assays were
carried out at 308C for 30 min before analysis
on SDS±PAGE, followed by autoradiography.
Approximately 10 ng of PKI was used in lane
2 to inhibit PKAc.
(B) 70Z/3 cells were labeled with 32Pi for 2 hr
before stimulation with LPS for 15 min. The
cells were lysed, p65 was immunoprecipi-
tated and separated by SDS±PAGE, and the
dried gel was exposed for autoradiography
for 3 hr. Lane 1 contained unstimulated cells;
lane 2 contained LPS-stimulated cells. After
reimmunoprecipitation with the p65 antibody
(Experimental Procedures), the secondary
immunoprecipitates were separated on SDS±
PAGE and detected by autoradiography for
40 hr (lane 3 contained unstimulated cells;
lane 4 contained LPS-stimulated cells). To ex-
amine the effect of IkB degradation on p65
phosphorylation, 32P-labeled 70Z/3 cells were
pretreated with PDTC (300 mM) (lane 5), cal-
pain inhibitor I (50 mM) (lane 6), and H-89 (40
mM) (lane 7) for 1 hr before stimulation with
LPS. The cells were lysed and subjected to
primary and secondary p65 immunoprecipi-
tations.
(C) The site for LPS-induced phosphorylation
on p65 was mapped using phosphopeptide
mapping. The 32P-labeled proteins from LPS-
stimulated cells were transferred to nitrocel-
lulose, and after autoradiography, the labeled
p65 band was excised and digested with the
indicated enzymes and CNBr. The upper
band in the trypsin lane probably results from
incomplete digestion.
(D) The sequence of the PKA phosphorylation site in p65 and the serine residue that is changed to alanine in the mutant are indicated. The
mutant protein is not phosphorylated by PKAc in vitro (data not shown). The wild-type and mutant p65 proteins were expressed in Jurkat
cells along with the pBIIx luc construct. Twenty-four hours after transfection, the transfected cells were harvested and the expressed luciferase
was quantitated. A concentration of 0.5 mg p65 was used for transfection in the subsequent assays.
(E) Jurkat cells were transfected with 0.5 mg of p65 (wild-type or mutant) and 1 mg of PKAc (wild-type or mutant), along with the pBIIx luc
reporter construct. Cells were harvested for luciferase assay 24 hr after transfection.
(F) Jurkat cells were transfected with p65 wild-type and mutant, along with the pBIIx luc, similar to that in (E). Twenty-four hours after
transfection, the indicated cells were treated with 50 mM dibutyryl cAMP for 2 hr, before harvesting all the samples to assay luciferase activity.
To test whether this effect of PKA on NF-kB activity that IkB-associated PKAc is regulated in a cAMP-inde-
pendent manner. Essentially, this is accomplished bycould be seen by costimulating cellswith PKA activators
such as dibutyryl cAMP, we transfected p65 into Jurkat replacing the regulatory subunit of PKA by IkB to form
a pool of cytosolic NF-kB±IkB±PKAc complex, in whichcells using the kB-dependent luciferase reporter and
stimulated them with dibutyryl cAMP (Figure 7F). How- the association between PKAc and NF-kB±IkB blocks
the catalytic activity of PKA. This pool of PKA is insensi-ever, costimulation with dibutyryl cAMP resulted in only
a modest stimulation of the transcriptional activity of tive to changes in levels of intracellular cAMP; instead,
treatment of cells with inducers of NF-kB activity thatNF-kB (Figure 7F). This suggests that efficient phos-
phorylation of p65 occurs only when PKAc is a compo- result in the degradation of IkB causes the activation of
this PKAc. We have also demonstrated that transcrip-nent of the NF-kB±IkB complex and, hence, is in close
vicinity to the substrate. This also suggests that cAMP- tional activity of NF-kB can be influenced through phos-
phorylation by PKA, a finding that brings NF-kB into theinduced PKA is unlikely to significantly affect the activity
of NF-kB. larger group of transcription factors whose activity can
be regulated directly by phosphorylation. Well charac-
terized examples include AP-1 and CREB, whose directDiscussion
phosphorylation by Jun kinases or PKA, respectively,
helps to determine whether the transcription factor isThe results presented in this paper describenovel mech-
anisms by which the activity of both PKA and NF-kB is able to activate transcription (Karin, 1995; Sassone-
Corsi, 1995). Therefore, in the case of NF-kB, it appearsregulated. The most surprising finding in this work is
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that its activity is regulated at two levels: (1) its release time when the Drosophila IkB homolog, Cactus, is de-
graded (Whalen and Steward, 1993; Gillespie and Was-from cytosolic complexes with IkB, and (2) its phosphor-
ylation at a specific site by PKA. Such a layering of serman, 1994). The knowledge that PKA might be acti-
vated during dorso-ventral patterning also raisesregulatory mechanisms might help cells to more finely
tune the expression of genes regulated by NF-kB. questions about the role that active PKA might play in
regulating the activity of other developmental regulatorsWe also show that inhibition of PKA activity in cells
treated with inducers of NF-kB activity does not signifi- such as the hedgehog protein.
It remains to be determined whether all NF-kB±IkBcantly affect the dissociation of NF-kB±IkB complexes,
the translocation of NF-kB to the nucleus, or the binding complexes contain PKAc, or whether a fraction of the
cytosolic NF-kB±IkB complexes can exist without PKAc.of NF-kB to DNA. Instead, what is dramatically affected
is the transcriptional activity of NF-kB, as determined The lack of associated PKAc in a fraction of the com-
plexes could have a significant regulatory impact if theseby its ability to drive transcription of a kB-dependent
reporter construct. This effect of PKA is mediated complexes were targeted differently from those con-
taining PKAc, since unphosphorylated NF-kB releasedthrough the direct phosphorylation of NF-kB p65 (Fig-
ures 7B and 7C), since a site-directed mutation at the from such PKAc-deficient NF-kB±IkB complexes would
be less effective transcriptionally. In such a scenario,consensus PKA phosphorylation site in p65 abolishes
the dependence of NF-kB on PKA for transcriptional the activity of unphosphorylated NF-kB might then be
regulated by costimulation with inducers that activateactivity (Figure 7F). We are also struck by the novelty
of the IkB±PKA interaction, since it appears to involve PKAc through the elevation of cAMP levels, although
we have found that cAMP-induced PKA does not signifi-N-terminal sequences of PKAc that comprise the ATP-
binding domain (Knighton et al., 1991b; Francis and Cor- cantly affect NF-kB activity (Figure 7F). However, such
a dependence of NF-kB activity on costimulation mightbin, 1994; Walsh and Van Patten, 1994). Since no other
protein that interacts specifically with this region of allow the cell to use NF-kB activity in two ways: (1)
unphosphorylated NF-kB could bind to kB sites andPKAc has been characterized, the structural features
used for this interaction remain to be defined (Francis drive low level transcription, or (2) NF-kB phosphory-
lated by PKA could drive transcription at a high level.and Corbin, 1994; Walsh and Van Patten, 1994). Al-
though theoretically the interaction of IkB proteins with In summary, the results presented in this report pro-
vide a novel insight into the regulation of two very impor-PKAc might allow the binding of the regulatory subunit
to the C terminus of PKAc, we have not observed any tant regulatory molecules in the cell, the transcription
factor NF-kB and the protein kinase PKA. In particular,PKAr in NF-kB±IkB±PKAc complexes. The lack of PKAr
in the NF-kB±IkB±PKAc complex might be due to steric the discovery of a novel mechanism for regulating PKA,
probably the most well studied protein kinase, wasfactors, or due to the interaction of the C-terminal sub-
strate binding region of PKAc with p65. Therefore, in highly surprising. We believe that the interaction be-
tween PKAc and ankyrin repeats might not be confinedour proposed model, the degradation of IkB leads to
the activation of PKAc by unmasking the ATP-binding to IkB proteins and might include other regulatory pro-
teins. Identifying other such anchors for PKAc will bedomain, and the active PKAc immediately phosphory-
lates p65, the substrate to which it is already bound. an important area of investigation in the future.
Such a coordinated phosphorylation might be neces-
sary, since in cells where the level of cAMP is unaltered, Experimental Procedures
free, active PKAr in the cytosol might rapidly inactivate
any released PKAc before it can phosphorylate its in- Purification of NF-kB±IkB and IkB from Rabbit Lung Cytosol
and Sequencing of the 42 kDa Copurifying Polypeptidetended substrate, p65, which is taken up into thenuclear
The purification of IkB proteins has been described previously (Fig-import pathway.
ure 1A) (Thompson et al., 1995). The 42 kDa band from the peakThe involvement of PKA in the regulation of Rel tran-
fraction of the Superose 12 column (step 8) was used for internal
scription factors has been most intensively studied in sequence analysis (Figure 1A), and three tryptic peptides were se-
Drosophila, where activation of PKA leads to the stimu- quenced. The yields of the three PKAc peptides were: T9, 1.5 pmol;
lation of transcription by Dorsal (Norris and Manley, T15, 1.2 pmol; and T 32, 1 pmol. The 42 kDa protein appears to
stain less efficiently with silver, since the yield of peptides from the1992). In addition, cotransfection of Dorsal with PKA
sequencing reactions indicated that it was present in equimolarleads to enhanced transcription, and the enhancement
amounts compared to peptides from IkB-b (T15-b, 1.4 pmol; T27-b,is blocked if a catalytic mutant of PKA is used (Norris
1.6 pmol; T41-b, 1.5 pmol) (Thompson et al., 1995). The mean ab-
and Manley, 1992). It has also been reported that Dorsal sorbance of peptide T32 from PKAc (24 amino acids, no Trp) at 214
is multiply phosphorylated concomitant to its entry into nm was 3.5 mAU, compared to peptide T27-b from IkB-b (21 amino
the nucleus in the embryo (Whalen and Steward, 1993; acids, no Trp), which was 3.0 mAU. Because these peptides are of
comparable length and devoid of Trp, they are likely to have similarGillespie and Wasserman, 1994). Despite these results,
molar extinction coefficients. Therefore, their equal absorption ata critical role for PKA in the activation of Dorsal has not
214 nm strongly suggests that the proteins from which they werebeen widely accepted because there was no explana-
derived were present in roughly equimolar amounts.
tion for how PKA might be activated during the time
when Dorsal was activated. Also, the inability to gener-
Antibodies and Reagentsate flies completely lacking PKA has prevented the di-
The sources of the different antibodies used were as follows: anti-
rect analysis of the role of PKA in dorso-ventral pat- p65 was from Biomol; anti-IkB-a (C-21) and anti-PKAr were from
terning (Lane and Kalderon, 1993). Our results provide Santa Cruz Biotechnology; anti-IkB-b was made in this laboratory
an explanation for how PKA may modulate the activity (Thompson et al., 1995); and anti-PKAc was a gift from Dr. Susan
Taylor (UCSD). The H-89 and ML-7 inihibitors were from Calbiochem.of Dorsal in a cAMP-independent manner during the
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The PKI (amino acids 6±22) amide peptide (TYADFIASGRTGRRNAI- proteins: Rel/dorsal homologies meet ankyrin-like repeats. Trends
Biochem. Sci. 17, 135±140.NH2), casein kinase II autophosphorylation inhibitory peptide
(QLQLQAASNFKSPVKTIR), forskolin, and dibutyryl cAMP were from Chen, D., and Rothenberg, E.V. (1994). Interleukin 2 transcription
Biomol. The fluorescent and biotinylated kempeptide assay kits for factors as molecular targets of cAMP Inhibition: delayed inhibition
PKA were from Promega, the TransPort cell permeabilization kit kinetics and combinatorial transcription roles. J. Exp. Med. 179,
was from GIBCO-BRL, and the Biotrak enzyme immunoassay kit for 931±942.
measuring cAMP levels was from Amersham.
DiDonato, J., Mercurio, F., Rosette, C., Wu-Li, J., Suyang, H., Ghosh,Immunoprecipitation and immunoblots were carried out using
S., and Karin, M. (1996). Mapping of the inducible IkB phosphoryla-protocols described previously (Thompson et al., 1995).
tion sites that signal its ubiquitination and degradation. Mol. Cell.
Biol. 16, 1295±1304.
Site-Directed Mutations of NF-kB p65 and PKAc
Francis, S.H., and Corbin, J.D. (1994). Structure and function ofSite directed mutations of NF-kB p65 and PKAc were generated
cyclic nucleotide-dependent protein kinases. Annu. Rev. Physiol.using PCR mutagenesis techniques. The sequences of the sense
56, 237±272.mutagenic oligos used were: p65, GCG ATC AGC AGG CCG CCG
TAG CTG; and PKAc, TAA GAT CAT CAT GGC GTA GTG G (the Gillespie, S.K., and Wasserman, S.A. (1994). Dorsal, a Drosophila
sites of mutations are indicated in bold). The 59 and 39 mutated PCR Rel-like protein, is phosphorylated upon activation of the transmem-
products were then run on agarose gels, purified, and mixed. PCR brane protein Toll. Mol. Cell. Biol. 14, 3559±3568.
reactions were then performed on this mixed template, using prim-
Hager, D.A., and Burgess, R.R. (1980). Elution of proteins from so-ers from the 59 and 39 ends of the respective cDNAs. The long PCR
dium dodecyl sulfate±polyacrylamide gels, removal of sodium dode-
product, corresponding to the entire cDNA, was then subcloned
cyl sulfate, and renaturation of enzymatic activity: results with sigma
into the pCDNA3 expression vector. The mutations were verified by
subunit of E. coli RNA polymerase, wheat germ DNA topoisomerase,
sequencing.
and other enzymes. Anal. Biochem. 109, 76±86.
Karin, M. (1995). The regulation of AP-1 activity by mitogen-activatedPKA Assay
protein kinases. J. Biol. Chem. 270, 16483±16486.In the phosphorylation of fluorescent kempeptide assay, addition
of phosphate to the peptide was assessed by its altered mobility Knighton, D.R., Zheng, J., TenEyck, L.F., Ashford, V.A., Xuong, N.-H.,
on an agarose gel run at neutral pH, where the phosphorylated Taylor, S.S., and Sowdaski, J.M. (1991a). Crystal structure of the
peptide migrates toward the anode (Figures 1C and 1D). The extent catalytic subunit of cyclic adenosine monophosphate±dependent
of phosphorylation was determined by quantitating the amount of protein kinase. Science 253, 407±414.
negatively charged peptide after scanning images of the fluorescent Knighton, D.R., Zheng, J., TenEyck, L.F., Xuong, N.-H., Taylor, S.S.,
gels. In all cases, the PKA activity is reported as folds over the PKA and Sowdaski, J.M. (1991b). Structure of a peptide inhibitor bound
activity in uninduced or untreated cells. to the catalytic subunit of cyclic adenosine monophosphate±
dependent protein kinase. Science 253, 414±420.
In Vivo Labeling and Phosphopeptide Mapping
Kopp, E., and Ghosh, S. (1995). NF-kB and rel proteins in innateCells were metabolically labeled with 32Pi, using previously pub-
immunity. Adv. Immunol. 58, 1±27.lished protocols (Naumann and Scheidereit, 1994; DiDonato et al.,
Lane, M.E., and Kalderon, D. (1993). Genetic investigation of cAMP-1996). To identify the labeled p65 protein, primary immunoprecipi-
dependent protein kinase function in Drosophila development.tates, using anti-p65, were boiled in 1% SDS buffer, diluted in TNT,
Genes Dev. 7, 1229±1243.and then reimmunoprecipitated with anti-p65 (Naumann and
Scheidereit, 1994). For carrying out phosphopeptide mapping, Mosialos, G., and Gilmore, T.D. (1992). v-Rel and c-Rel are differen-
primary anti-p65 immunoprecipitates were fractionated by SDS± tially affected by mutations at a consensus protein kinase recogni-
PAGE and transferred to nitrocellulose. The phosphorylated p65 was tion sequence. Oncogene 8, 721±730.
identified by autoradiography, excised, and digested with trypsin,
Naumann, M., and Scheidereit, C. (1994). Activation of NF-kB in vivochymotrypsin, LysC, and CNBr, following established protocols (Di-
is regulated by multiple phosphorylations. EMBO J. 13, 4597±4607.Donato et al., 1996). The resulting peptides were analyzed by Tris-
Neumann, M., Grieshammer, T., Chuvpilo, S., Kneitz, B., Lohoff, M.,tricine gel electrophoresis (Schagger and von Jagow, 1987), and
Schimpl, A., Franza, B.R., Jr., and Serfling, E. (1995). RelA/p65 is athe phosphorylated peptides were detected by autoradiography.
molecular target for the immunosuppressive action of protein kinaseThe molecular weight markers were used to generate a calibration
A. EMBO J. 14, 1991±2004.curve, and the Rf values of the phosphopeptides were used to
determine their molecular weights. Norris, J.L., and Manley, J.L. (1992). Selective nuclear transport of
the Drosophila morphogen dorsal can be established by a signaling
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